Clinical Trial Update: Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating adaptive radiotherapy to reduce xerostomia in oropharynx cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: Center Eugene Marquis | Conditions: Oropharynx Cancer | Phase 3 | Status: COMPLETED